Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages
- PMID: 2891100
- DOI: 10.1203/00006450-198710000-00013
Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages
Abstract
Mucoid Pseudomonas aeruginosa is an important respiratory pathogen in patients with cystic fibrosis, and once acquired is virtually impossible to eradicate. Although mucoid P. aeruginosa is generally believed to be resistant to phagocytosis, the mechanism is not understood fully. We studied the nonopsonic phagocytosis by human neutrophils or macrophages of eight mucoid/nonmucoid P. aeruginosa pairs (three isogenic and five "wild-type"). Mucoid strains were relatively resistant to nonopsonic phagocytosis but the nonmucoid types were phagocytosis-susceptible as assessed by visual inspection and chemiluminescence assays. The mucoid and nonmucoid variants had equal numbers of pili but different surface characteristics as determined by biphasic partitioning in polyethylene glycol and dextran. The mucoid exopolysaccharide of mucoid strains appears to alter the surface characteristics of P. aeruginosa thereby rendering them resistant to nonopsonic phagocytosis. The resistance of mucoid variants of P. aeruginosa to nonopsonic phagocytosis may provide a survival advantage to these bacteria early in the course of pulmonary infection before opsonic antibody and complement are present in respiratory secretions.
Similar articles
-
Opsonin-independent phagocytosis of Pseudomonas aeruginosa.Antibiot Chemother (1971). 1985;36:88-94. doi: 10.1159/000410474. Antibiot Chemother (1971). 1985. PMID: 3923915
-
Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.Clin Invest Med. 1982;5(2-3):125-8. Clin Invest Med. 1982. PMID: 6811181
-
Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients.Infect Immun. 1984 Mar;43(3):1006-11. doi: 10.1128/iai.43.3.1006-1011.1984. Infect Immun. 1984. PMID: 6421734 Free PMC article.
-
Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.APMIS Suppl. 1992;28:1-79. APMIS Suppl. 1992. PMID: 1449848 Review.
-
Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway.Semin Respir Infect. 1992 Sep;7(3):168-78. Semin Respir Infect. 1992. PMID: 1475541 Review.
Cited by
-
Interactions of Neutrophils with the Polymeric Molecular Components of the Biofilm Matrix in the Context of Implant-Associated Bone and Joint Infections.Int J Mol Sci. 2023 Dec 1;24(23):17042. doi: 10.3390/ijms242317042. Int J Mol Sci. 2023. PMID: 38069365 Free PMC article. Review.
-
Scorpionfish BPI is highly active against multiple drug-resistant Pseudomonas aeruginosa isolates from people with cystic fibrosis.Elife. 2023 Jul 18;12:e86369. doi: 10.7554/eLife.86369. Elife. 2023. PMID: 37461324 Free PMC article.
-
Subversion of the Complement System by Pseudomonas aeruginosa.J Bacteriol. 2023 Aug 24;205(8):e0001823. doi: 10.1128/jb.00018-23. Epub 2023 Jul 12. J Bacteriol. 2023. PMID: 37436150 Free PMC article. Review.
-
Mechanism of resistance to phagocytosis and pulmonary persistence in mucoid Pseudomonas aeruginosa.Front Cell Infect Microbiol. 2023 Mar 15;13:1125901. doi: 10.3389/fcimb.2023.1125901. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37009499 Free PMC article.
-
Direct Inhibition of RetS Synthesis by RsmA Contributes to Homeostasis of the Pseudomonas aeruginosa Gac/Rsm Signaling System.J Bacteriol. 2022 Mar 15;204(3):e0058021. doi: 10.1128/jb.00580-21. Epub 2022 Jan 18. J Bacteriol. 2022. PMID: 35041497 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
